non-nucleoside reverse transcriptase inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenon-nucleoside reverse transcriptase inhibitors (Bristol-Myers Squibb)
Drug Alias NameNNRTIs (Bristol-Myers Squibb)efavirenz analogs (DuPont)non-nucleoside reverse transcriptase inhibitors (BMS)NNRTIs (BMS)efavirenz analogs (BMS) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A